Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
Sabine Ettinger,1 Michal Stanak,1 Piotr Szymański,2 Claudia Wild,1 Romana Tandara Haček,3 Darija Erčević,3 Renata Grenković,3 Gregor Goetz,1 Mirjana Huić3 1Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria; 2Institute of Cardiology, Warsaw, Poland; 3Department for Developm...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08bd05f192f546ea9d8e63aa5c2918ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:08bd05f192f546ea9d8e63aa5c2918ef |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:08bd05f192f546ea9d8e63aa5c2918ef2021-12-02T04:14:57ZReply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”1179-1470https://doaj.org/article/08bd05f192f546ea9d8e63aa5c2918ef2019-03-01T00:00:00Zhttps://www.dovepress.com/reply-to-comments-on-the-authors-reply-to-the-critical-appraisal-conce-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Sabine Ettinger,1 Michal Stanak,1 Piotr Szymański,2 Claudia Wild,1 Romana Tandara Haček,3 Darija Erčević,3 Renata Grenković,3 Gregor Goetz,1 Mirjana Huić3 1Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria; 2Institute of Cardiology, Warsaw, Poland; 3Department for Development, Research, and Health Technology Assessment, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, CroatiaAlthough we clearly outlined our answers in our previous letter,1 we are pleased to clarify further any remaining open issues. There might be diverse views with regard to comparators of the wearable cardioverter defibrillator (WCD). We would like to refer the readers to our previous answer,1 where we explained our rationale for choosing the implantable cardioverter defibrillator as one of the comparators. It was selected based on broad indications stated in the CE mark and after discussions with clinicians. Furthermore, in this case, a change of the comparator, ie, the implantable cardioverter defibrillator, would not have led to a different result or conclusion.View the original paper by Ettinger and colleagues.Two previous letters have been published Sperzel et al Sperzel et alEttinger SStanak MSzymański PWild CTandara Haček RErčević DGrenković RGoetz GHuić MDove Medical PressarticleN/AMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 12, Pp 129-131 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
N/A Medical technology R855-855.5 |
spellingShingle |
N/A Medical technology R855-855.5 Ettinger S Stanak M Szymański P Wild C Tandara Haček R Erčević D Grenković R Goetz G Huić M Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
description |
Sabine Ettinger,1 Michal Stanak,1 Piotr Szymański,2 Claudia Wild,1 Romana Tandara Haček,3 Darija Erčević,3 Renata Grenković,3 Gregor Goetz,1 Mirjana Huić3 1Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria; 2Institute of Cardiology, Warsaw, Poland; 3Department for Development, Research, and Health Technology Assessment, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, CroatiaAlthough we clearly outlined our answers in our previous letter,1 we are pleased to clarify further any remaining open issues. There might be diverse views with regard to comparators of the wearable cardioverter defibrillator (WCD). We would like to refer the readers to our previous answer,1 where we explained our rationale for choosing the implantable cardioverter defibrillator as one of the comparators. It was selected based on broad indications stated in the CE mark and after discussions with clinicians. Furthermore, in this case, a change of the comparator, ie, the implantable cardioverter defibrillator, would not have led to a different result or conclusion.View the original paper by Ettinger and colleagues.Two previous letters have been published Sperzel et al Sperzel et al |
format |
article |
author |
Ettinger S Stanak M Szymański P Wild C Tandara Haček R Erčević D Grenković R Goetz G Huić M |
author_facet |
Ettinger S Stanak M Szymański P Wild C Tandara Haček R Erčević D Grenković R Goetz G Huić M |
author_sort |
Ettinger S |
title |
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
title_short |
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
title_full |
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
title_fullStr |
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
title_full_unstemmed |
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
title_sort |
reply to: comments on the authors’ reply to the critical appraisal concerning “wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study” |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/08bd05f192f546ea9d8e63aa5c2918ef |
work_keys_str_mv |
AT ettingers replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT stanakm replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT szymanskip replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT wildc replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT tandarahacekr replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT ercevicd replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT grenkovicr replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT goetzg replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo AT huicm replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo |
_version_ |
1718401349541953536 |